Journal of Experimental Medicine, Vol 180, 1817-1827, Copyright © 1994 by Rockefeller University Press

ARTICLES

Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras

M Tary-Lehmann, PV Lehmann, D Schols, MG Roncarolo and A Saxon
Hart and Louise Lyon Laboratory, Department of Medicine, University of California at Los Angeles 90024.

Injecting human peripheral blood mononuclear cells into severe combined immunodeficient (SCID) mice results in long-term engraftment of human lymphocytes, of which > 98% are phenotypically mature, activated T cells. Here we have characterized the human T cells that populate such hu-PBL-SCID chimeras. We report that these human T cells do not mobilize Ca2+ after CD3 stimulation, i.e., their T cell receptor (TCR)- mediated signal transduction is deficient. Chimera-derived human T cells do not secrete lymphokines or undergo blastogenesis after CD3 stimulation, but proliferate in response to interleukin 2 (IL-2), defining the chimera derived human T cells as anergic. Anergy was seen in both the CD4+ and the CD8+ subpopulations. We established human T cell lines from chimeras. These T cells retained their anergic state for 1-2 mo in culture, after which they simultaneously regained the ability to mobilize Ca2+, secrete lymphokines, and to undergo blastogenesis following stimulation via the TCR. Once regaining proliferative responsiveness to CD3 stimulation, these CD4+ T cell lines displayed anti-SCID mouse reactivity and showed no specificity for recall antigens. All CD3-responsive CD4+ T cell clones obtained from such lines were SCID mouse specific, recognizing native major histocompatibility complex class II products on the murine cells. In contrast, chimera-derived human CD8+ cell lines and clones did not display detectable anti-mouse reactivity. The data show that the human T cell system in long term hu-PBL-SCID chimeras is nonfunctional due to both anergy and the limitation of the CD4+ repertoire to xenoreactive clones. The data suggest that long-term hu-PBL-SCID chimerism represents an atypical graft-versus-host reaction in which the human effector T cells become anergic in the murine environment.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Jiang, Q., Zhang, L., Wang, R., Jeffrey, J., Washburn, M. L., Brouwer, D., Barbour, S., Kovalev, G. I., Unutmaz, D., Su, L. (2008). FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-{gamma}C-/- mice in vivo. Blood 112: 2858-2868 [Abstract] [Full Text]  
• Zhang, L., Kovalev, G. I., Su, L. (2007). HIV-1 infection and pathogenesis in a novel humanized mouse model. Blood 109: 2978-2981 [Abstract] [Full Text]  
• May, K. F. Jr, Roychowdhury, S., Bhatt, D., Kocak, E., Bai, X.-F., Liu, J.-Q., Ferketich, A. K., Martin, E. W. Jr, Caligiuri, M. A., Zheng, P., Liu, Y. (2005). Anti-human CTLA-4 monoclonal antibody promotes T-cell expansion and immunity in a hu-PBL-SCID model: a new method for preclinical screening of costimulatory monoclonal antibodies. Blood 105: 1114-1120 [Abstract] [Full Text]  
• Islas-Ohlmayer, M., Padgett-Thomas, A., Domiati-Saad, R., Melkus, M. W., Cravens, P. D., Martin, M. d. P., Netto, G., Garcia, J. V. (2004). Experimental Infection of NOD/SCID Mice Reconstituted with Human CD34+ Cells with Epstein-Barr Virus. J. Virol. 78: 13891-13900 [Abstract] [Full Text]  
• Skapenko, A., Niedobitek, G. U., Kalden, J. R., Lipsky, P. E., Schulze-Koops, H. (2004). Generation and Regulation of Human Th1-Biased Immune Responses In Vivo: A Critical Role for IL-4 and IL-10. J. Immunol. 172: 6427-6434 [Abstract] [Full Text]  
• Tsark, E. C., Dao, M. A., Wang, X., Weinberg, K., Nolta, J. A. (2001). IL-7 Enhances the Responsiveness of Human T Cells That Develop in the Bone Marrow of Athymic Mice. J. Immunol. 166: 170-181 [Abstract] [Full Text]  
• Wagar, E. J., Cromwell, M. A., Shultz, L. D., Woda, B. A., Sullivan, J. L., Hesselton, R. M., Greiner, D. L. (2000). Regulation of Human Cell Engraftment and Development of EBV-Related Lymphoproliferative Disorders in Hu-PBL-scid Mice. J. Immunol. 165: 518-527 [Abstract] [Full Text]  
• Fais, S., Lapenta, C., Santini, S. M., Spada, M., Parlato, S., Logozzi, M., Rizza, P., Belardelli, F. (1999). Human Immunodeficiency Virus Type 1 Strains R5 and X4 Induce Different Pathogenic Effects in hu-PBL-SCID Mice, Depending on the State of Activation/Differentiation of Human Target Cells at the Time of Primary Infection. J. Virol. 73: 6453-6459 [Abstract] [Full Text]  
• Delhem, N., Hadida, F., Gorochov, G., Carpentier, F., de Cavel, J.-P., Andreani, J.-F., Autran, B., Cesbron, J.-Y. (1998). Primary Th1 Cell Immunization Against HIVgp160 in SCID-hu Mice Coengrafted with Peripheral Blood Lymphocytes and Skin. J. Immunol. 161: 2060-2069 [Abstract] [Full Text]  
• Brams, P., Nguyen, M.-L., Chamat, S., Royston, I., Morrow, P. R. (1998). Antigen-Specific IgG Responses from Naive Human Splenocytes: In Vitro Priming Followed by Antigen Boost in the SCID Mouse. J. Immunol. 160: 2051-2058 [Abstract] [Full Text]  
• Coppola, V., Veronesi, A., Indraccolo, S., Calderazzo, F., Mion, M., Minuzzo, S., Esposito, G., Mauro, D., Silvestri, B., Gallo, P., Falagiani, P., Amadori, A., Chieco-Bianchi, L. (1998). Lymphoproliferative Disease in Human Peripheral Blood Mononuclear Cell-Injected SCID Mice. IV. Differential Activation of Human Th1 and Th2 Lymphocytes and Influence of the Atopic Status on Lymphoma Development. J. Immunol. 160: 2514-2522 [Abstract] [Full Text]  
• Garcia, S., Dadaglio, G., Gougeon, M.-L. (1997). Limits of the Human-PBL-SCID Mice Model: Severe Restriction of the Vbeta T-Cell Repertoire of Engrafted Human T Cells. Blood 89: 329-336 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS